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a b s t r a c t
After the introduction of total mesorectal excision (TME) and radiochemotherapy, excel-
lent results have been achieved in the treatment of patients with rectal cancer. With better 
oncologic control of the disease, the functional results of this type of therapeutic approach 
and their impact on the quality of life (QOL) of patients started to be increasingly valued. 
The aims of this study were to evaluate the QOL of patients with rectal cancer submitted 
to TME in the late postoperative period and the possible factors that directly influence 
their quality of life. A total of 72 patients submitted to TME due to extraperitoneal rectal 
tumor were assessed, after at least one postoperative year, by applying QOL question-
naires (EORTC QLQ-C30 and EORTC QLQ-CR38), in addition to a specific clinical question-
naire and rectal examination. Patients were evaluated regarding gender, age, indication of 
radiotherapy and chemotherapy preoperatively, length of postoperative period, distance 
from the anastomosis to the anal verge and general health status. The mean overall health 
status of patients was satisfactory (82.06). There was no difference in overall health sta-
tus between patients with respect to gender, but the male patients had less insomnia 
(p = 0.002), better future prospects (p = 0.011), fewer effects of chemotherapy (p = 0.020) 
and better sexual function (p < 0.0001). Patients younger than 50 years had fewer urinary 
problems (p = 0.035), whereas those older than 65 years reported poorer sexual function 
(p = 0.012). Patients who underwent neoadjuvant therapy had more diarrhea (p = 0.012). 
Quality of life did not change significantly with time after surgery and the distance from 
the anastomosis to the anal verge. We conclude that patients undergoing TME have a good 
quality of life one year after the surgery and that the factors capable of affecting QOL 
should be identified and improved.
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r e s u m o
Avaliação da qualidade de vida de pacientes com câncer de reto 
submetidos a excisão total do mesorreto em pós-operatório tardio
A introdução da cirurgia de excisão total do mesorreto (ETM) e da radioquimioterapia pro-
piciaram excelentes resultados no tratamento do câncer de reto. Com o melhor controle 
oncológico da doença, os resultados funcionais deste tipo de abordagem terapêutica e 
seu impacto na qualidade de vida (QV) dos pacientes passaram a ser cada vez mais valo-
rizados. Os objetivos do presente estudo foram avaliar a QV dos pacientes portadores de 
câncer retal submetidos à ETM, em pós-operatório tardio e os possíveis fatores capazes 
de influenciar diretamente na qualidade de vida dos mesmos.  Foram avaliados 72 pa-
cientes submetidos à ETM por tumor de reto extraperitoneal, com no mínimo, um ano de 
pós-operatório, por meio da aplicação de questionários de QV (EORTC QLQ-C30 e EORTC 
QLQ-CR38), além de questionário clínico específico e exame proctológico. Os pacientes 
foram avaliados quanto a gênero, idade, realização de radioterapia e quimioterapia pré-
-operatórias, tempo de pós-operatório, distância da anastomose à margem anal e estado 
global de saúde. A média do estado global de saúde dos pacientes avaliados foi satisfató-
ria (82,06). Não se observou diferença na saúde global entre os pacientes com relação ao 
gênero, porém os pacientes do sexo masculino apresentaram menos insônia (p = 0,002), 
melhores perspectivas futuras (p = 0,011), menos efeitos da quimioterapia (p = 0,020) e 
melhor função sexual (p < 0,0001). Os pacientes com menos de 50 anos apresentaram 
menos problemas miccionais (p = 0,035), já os com mais de 65 anos relataram uma pior 
função sexual (p = 0,012). Os pacientes que realizaram neoadjuvância apresentaram mais 
diarreia (p = 0,012). A qualidade de vida não se alterou significativamente de acordo com 
o tempo de pós-operatório e distância da anastomose à margem anal. Conclui-se que 
os pacientes submetidos à ETM apresentam uma boa qualidade de vida após um ano 
de cirurgia e que os fatores envolvidos capazes de influenciar a QV devem ser identifica-
dos e otimizados.
Introduction
The multimodal therapy currently used for the treatment of 
rectal cancer has enabled great success in disease control. In 
contrast, advances in multimodal therapy were not as evident 
in terms of functional outcomes, especially in tumors located 
in the extraperitoneal rectum. The total mesorectal excision 
(TME) surgery with radiotherapy and chemotherapy can re-
sult in side effects such as increased defecation frequency 
and urgency, as well as sexual and urinary dysfunction, which 
may directly influence patient quality of life (QOL).
The pursuit of quality of life by achieving better functional 
outcomes related to the surgical treatment of rectal cancer 
was initially emphasized in the 1970s. Since then, this aspect 
of treatment has been increasingly valued, and is currently of 
great importance in the treatment of the disease.1
Once excellent oncological results have been achieved 
leading to an increase in survival, it became apparent the 
concern with the functional results of this therapeutic ap-
proach, as well as the mechanisms involved in its genesis 
and the ways to improve them. Since the introduction of TME 
as the standard treatment for middle and low rectal cancer, 
several late functional results have been observed in patients 
submitted to surgery, although not always shown in a well-
structured and reliable manner. 
Thus, it becomes of great interest to perform a precise and 
objective QOL assessment, as well as of factors that could in-
fluence QOL improvement. Therefore, this study aims to eval-
uate the QOL of patients with rectal cancer submitted to TME 
in the late postoperative period, by applying validated ques-
tionnaires with emphasis on anorectal, as well as sexual and 
urinary functions, seeking to identify possible factors capable 
of directly influencing QOL. 
Methods
A total of 72 patients undergoing total mesorectal excision 
for extra-peritoneal rectal adenocarcinoma were evaluated, 
at least one year postoperatively, which were selected from 
direct analysis of patients’ charts from the Service of Colo-
proctology of Hospital Felicio Rocho, from January 2000 to 
December 2009. All patients were operated on by surgeons 
specialized in colorectal surgeries with adequate training to 
perform the TME technique with low colorectal or coloanal 
anastomosis, with or without radiotherapy and/or associ-
ated chemotherapy. 
Patients with locoregional or systemic recurrence, ostomy 
patients, patients with other malignancies capable of impact-
ing on quality of life, terminal patients and those with severe 
decompensated systemic disease and great negative impact 
on overall quality of life were excluded from the study. Pa-
tients with cognitive deficits, decompensated psychiatric 
disorders and illiterate patients unable to read and/or under-
stand the questionnaires and their correct completion were 
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also excluded, as well as those who did not appropriately fill 
out the questionnaires or failed to respond all or most of the 
questionnaire questions. 
Patients were contacted by telephone and informed about 
the study. Those who agreed to participate were recruited for 
the interview and physical examination. 
Patients were interviewed and examined at the Coloproc-
tology Outpatient Clinic of Hospital Felicio Rocho or in private 
practice and filled out the questionnaires in a private room, 
alone and in quietness. Some patients preferred to answer 
the questionnaires in their homes and return them after 
completion. Doubts on any question were always clarified by 
one of the researchers (PRFN), so that all questionnaires were 
answered adequately.
The quality of life of patients was assessed through the 
EORTC QLQ-C30 and EORTC QLQ-CR38 questionnaires. A spe-
cific standardized clinical questionnaire, developed by the re-
searchers, was also used to assess whether the patient had 
undergone neoadjuvant and adjuvant treatments, presence 
of comorbidities and postoperative time. Patients underwent 
anorectal examination that included assessment of the dis-
tance from the anastomosis to the anal verge, by digital exam 
and measuring the distance found with a ruler. All data ob-
tained from the questionnaires, as well as anorectal exami-
nation, were entered in the spreadsheet software in Micro-
soft Office Excel (2007) and statistical analysis was performed 
with SPSS, release 13.0 (SPSS Inc., Chicago, IL, USA).  
The EORTC QLQ-C30 questionnaire contains 30 items that 
can be subdivided into five functional scales (physical, perfor-
mance, emotional, cognitive and social), a measure of over-
all quality of life, symptom assessment (fatigue, nausea and 
vomiting, pain, dyspnea, insomnia, loss of appetite, constipa-
tion and diarrhea) and evaluation of financial difficulties.2-4
The EORTC QLQ-CR38 was designed especially for the eval-
uation of colorectal cancer (CRC) therapy from the patient’s 
perspective.5 It is subdivided into four functional scales: body 
image, future prospects, sexual pleasure and sexual function, 
plus eight symptom scales: problems with urination, gas-
trointestinal symptoms, side effects of chemotherapy, def-
ecation problems, stoma-related problems, male and female 
sexual problems and weight loss.
The 68 questions of the EORTC QLQ-C30 and QLQ-CR38 
questionnaires were designed to be aggregated, resulting in 
27 variables for analysis. Patients’ answers were combined 
and converted into a scale of 0 to 100 according to the rec-
ommendations provided by EORTC.3 Each patient’s score was 
expressed as a number in a scale of 0 to 100, where 0 is the 
worst and 100 the best in functional scales and 0 represents 
the best and 100 the worst in symptom scales. A high score 
for a functional scale represents a higher functional level, and 
a high score for overall health status represents high quality 
of life. Moreover, a high score for a symptom scale represents 
high level of symptoms and problems. 
Among the items evaluated, the overall health status is 
assessed in EORTC QLQ-C30. Patients with a score > 80 on a 
scale ranging from 0 to 100 have good quality of life.
After the EORTC QLQ-C30 and QLQ-CR38 questionnaires 
were applied, scores were calculated for each assessed item, 
as recommended by the EORTC. Then, these scores were 
compared between males and females, between different 
age groups, among patients who underwent neoadjuvant ra-
diochemotherapy and those who did not, between different 
postoperative periods and different distances from the anas-
tomosis to the anal verge. 
Regarding age, patients were divided into three groups: a 
group up to 50 years old, a group aged 50 years and one day to 
65 years old and a group older than 65 years and one day old. 
According to the postoperative time, patients were divided 
into three groups. The first group consisted of patients with 1 
year and a day up to 2 years postoperatively, the second group 
with 2 years and one day to four years postoperatively and the 
third group with more than 4 years and 1 day postoperatively. 
In relation to the distance from the anastomosis to the anal 
verge, the patients were divided into three groups: the first 
group with up to 2 cm from the anal verge of the anastomosis, 
the second group with 2.1 cm to 5 cm and the third group with 
a distance ≥ 5.1 cm.
Patients were also divided according to the overall health 
status into two groups (score greater than 80 and less than 
80), and the statistical analysis was performed between these 
two groups and the scales of function and symptoms of the 
EORTC QLQ-C30 and EORTC QLQ-CR38 questionnaires. 
This study was approved by the research ethics committee 
of Hospital Felicio Rocho and Universidade Federal de Minas 
Gerais (SISNEP 0001.0.240.000-08). The EORTC QLQ-C30 and 
EORTC QLQ-CR38 questionnaires had their use authorized by 
the EORTC Quality of Life Group for this study.
Statistical Analysis 
The number of patients in the sample was defined by sample 
calculation as a minimum of 72 to achieve a significance level 
of 5% in all domains of the EORTC QLQ-C30 and EORTC QLQ-
CR38 questionnaires. The analysis of the variables related to 
the quality of life indicators obtained from the scales was 
compared through means for data with normal distribution 
and medians for the others. We also compared the quality of 
life variables with the data regarding gender, age range, pres-
ence of neoadjuvant therapy, postoperative time, distance 
from the anastomosis to the anal verge and overall health 
status. The t test was used for variables with normal distribu-
tion. Kruskal-Wallis and Mann-Whitney tests were applied to 
the other variables. P values  < 0.05 were considered statisti-
cally significant.  
Results
Among the 72 patients evaluated, there was a predominance 
of males (n = 39, 54.2%) with a mean age of 61.9 years, and 
most were between 50 and 65 years (n = 32, 44.4%). Regard-
ing patient comorbidities, hypertension and diabetes mellitus 
were the most prevalent ones (n = 19 and n = 8, respectively). 
Neoadjuvant treatment with radiotherapy and chemotherapy 
was performed in 35 patients (48.6%), while seven (9.7%) were 
referred for radiotherapy in the postoperative period associ-
ated with systemic chemotherapy. Thus, 42 patients (58.33%) 
underwent multimodal treatment with surgery, radiotherapy 
and chemotherapy, performed pre or postoperatively. The 
mean post-operative follow-up of patients was four years 
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(ranging from 1-11 years). Regarding the distance from the 
anastomosis to the anal verge, the first group with distance 
from the anastomosis to the anal verge up to 2 cm consisted 
of 15 patients (20.83%), the second group with distance from 
2.1 cm to 5 cm consisted of 47 patients (65.27%) and the third 
group with a distance ≥ 5.1 cm consisted of 10 patients (13.9%). 
Regarding gender, when evaluating the results of the 
EORTC QLQ-C30 questionnaire, it was observed that for the 
overall health status, the medians were similar, but men had 
less insomnia than women, and this was the only symp-
tom that showed a statistically significant difference among 
genders (p = 0.002). 
When assessing the EORTC QLQ-CR38 questionnaire, it 
was observed that men had better sexual function (p < 0.0001) 
and better future prospects (p = 0.011) than women. Regard-
ing the symptom scales, women had worse effects of chemo-
therapy (p = 0.02).
With regard to age, there were no statistically significant 
differences between the groups in relation to the EORTC QLQ-
C30 questionnaire. Regarding the EORTC QLQ-CR38 question-
naire, patients up to 50 years had fewer urinary problems (p 
= 0.035). Patients aged between 50 and 65 years reported bet-
ter sexual function (p = 0.012), which worsened in those older 
than 65 years. Regarding other items assessed there was no 
statistically significant difference between groups (Fig. 1). 
Regarding patients submitted or not to neoadjuvant radio-
therapy and chemotherapy, it was observed that patients who 
underwent this preoperative approach had more diarrhea than 
those who did not (p = 0.012), and that was the only change 
with statistical significance. 
There were no statistically significant differences between 
the items assessed in the EORTC QLQ-C30 and EORTC QLQ-
CR38 questionnaires in relation to the three age groups as-
sessed and postoperative follow-up.
The only statistically significant data related to the dis-
tance from the anastomosis to the anal verge was that pa-
tients with a distance greater than or equal to 5 cm had a 
worse effect of chemotherapy (p = 0.032) compared to pa-
tients with a lower anastomosis. 
Regarding the overall health status, 44 patients (61.1%) had 
scores ≥ 80. The mean overall health status was 82.06, being 
84.60 and 79.91, for males and females, respectively. Regard-
ing age range, this same mean in patients up to 50 years was 
85.42; between 50 and 65 years, it was 80.21 and above 65 
years, it was 82.74.
Regarding the EORTC QLQ-C30 questionnaire, patients 
with an overall health status with scores > 80 had better phys-
ical function (p = 0.043), better emotional (p = 0.028) and social 
function (p < 0.0001) and less fatigue (p = 0.006). When the 
EORTC QLQ-CR38 items were assessed in patients with overall 
health status scores > 80, there were better future prospects 
(p = 0.032), fewer gastrointestinal symptoms (p = 0.010) and 
fewer defecation problems (p = 0.009) (Tables 1 and 2). 
Discussion
The factors that influence quality of life of patients treated for 
rectal cancer should be progressively known and studied in an 
attempt to modify them, as to continue to provide an adequate 
quality of life to patients, in addition to effective disease control.
Several studies have investigated potential factors that in-
fluence functional outcomes in rectal cancer treatment.6-8 The 
main factors that have been described are: gender, age, use of 
radiotherapy and chemotherapy, postoperative time and dis-
tance from the colorectal anastomosis to the anal verge.
Regarding gender, there was no difference in overall health 
between males and females, although males had less insom-
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Fig. 1 – Quality of life assessment through the EORTC QLQ-CR38 questionnaire in relation to age.
J  C O L O P R O C T O L .  2 0 1 3 ; 3 3 ( 2 ) : 5 0 – 5 754
nia (p = 0.002), better future prospects (p = 0.011) and fewer 
effects of chemotherapy (p = 0.020). This has been described 
by other authors, who also found less insomnia among men, 
as well as less pain, loss of appetite and fatigue.9,10 It has been 
suggested that the gender difference may be attributed to the 
attitude adopted by male patients, who tend to avoid answers 
that demonstrate weakness or dependency.11 
Male patients showed better sexual function (p < 0.0001), 
which is in disagreement with the results found by other au-
thors.7,12,13 Sexual problems usually occur due to damage to 
pelvic autonomic nerves and the pelvic floor during dissec-
tion of the rectum14,15 and also by radiotherapy effects.16 Some 
studies indicate, however, that part of the problem with post-
operative sexual function may also be due to psychological 
factors and effects of advanced age at the time of surgery.17,18 
The mean age of female and male patients in our study was 
62 and 61 years, respectively, so probably age had no signifi-
cant effect on the sexual alterations, if we take gender into 
account. Psychological issues are extremely important in a 
satisfactory sexual activity. The psychological factors in the 
present study probably had a negative effect on the female 
patients, represented by worse emotional function, than that 
reported by men. 
Other aspects that must be considered are the taboos and 
prejudices still present in the Brazilian society, with respect 
to sexual activity. In general, males tend to omit unfavorable 
facts related to sexual activity when compared to women. 
It can still be considered very embarrassing for a male indi-
vidual to reveal disclose erectile or ejaculatory dysfunctions 
or other difficulties during sex, in general. In this case, the 
information provided by patients does not always represent 
the reality.
Regarding age, patients older than 65 had worse sexual 
function than younger ones (p = 0.012). This was also ob-
served by other authors, who considered age as the factor 
more strongly related to the risk of loss of sexual function.19,20
The sexual function of patients between 50 and 65 years 
was better than that of patients younger than 50 years, which 
is also consistent with the observation by Schmidt et al.19 This 
is probably due to the fact that sexual performance assess-
Table 1 – Overall health status assessment in relation to the items of EORTC QLQ-C30 questionnaire.
EORTC QLQ-C30 Overall health status p value
< 80 ≥ 80
Median Interquartile 
interval 
Median Interquartile 
interval
Physical function 93.33 20.00 100.00 6.67 0.043*
Role performance 100.00 29.17 100.00 0.00 —
Emotional function 75.00 41.67 91.67 33.33 0.028*
Cognitive function 83.33 33.33 100.00 33.33 0.352
Social function 83.33 33.33 100.00 0.00 < 0.0001*
Fatigue 11.11 30.56 0.00 11.11 0.006*
Nausea and vomiting 0.00 0.00 0.00 0.00 —
Pain 0.00 0.00 0.00 0.00 —
Dyspnea 0.00 0.00 0.00 0.00 —
Insomnia 0.00 33.33 0.00 33.33 —
Loss of appetite 0.00 0.00 0.00 0.00 —
Intestinal constipation 0.00 33.33 0.00 33.33 —
Diarrhea 0.00 58.33 0.00 33.33 0.349
Financial difficulty 0.00 33.33 0.00 0.00 —
* p value with significance < 0.05.
Table 2 – Overall health status assessment in relation to items of the EORTC QLQ-C38 questionnaire.
EORTC QLQ-CR38 Overall health status p value
< 80 ≥ 80
Median Interquartile 
interval 
Median Interquartile 
interval
Body image 88.89 41.67 100 22.22 0.134
Sexual function  66.67 33.34 33.33 58.34 0.682
Sexual fulfillment 66.67 33.34 66.67 66.67 0.108
Future prospects 33.33 66.67 66.67 66.67 0.032*
Urinary disorders 33.33 22.22 33.33 30.55 0.434
Chemotherapy effects 11.11 11.11 0.00 22.22 0.651
Gastrointestinal symptoms 20.00 23.34 6.67 20.00 0.010*
Female sexual problems 100.00 100.00 41.67 33.33 0.545
Male sexual problems 66.67 58.34 33.33 45.83 0.071
Bowel movement disorders 23.81 22.61 14.29 17.86 0.009*
Weight loss 0.00 33.33 0.00 0.00 —
* p value with significance < 0.05.
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ment was more stringent in younger patients. Patients up to 
50 years had fewer urinary problems (p = 0.035), as observed 
by Mastracci et al.21 That is because prostate changes in males 
and urinary incontinence in women occur mainly in older pa-
tients, definitely influencing the occurrence of urinary disor-
ders, most commonly found in this older age group. 
Patients who underwent neoadjuvant therapy had more 
diarrhea than those who did not (p = 0.012). Sphincter func-
tion impairment has been a concern when performing pelvic 
radiotherapy, which can result in marked worsening of conti-
nence associated with loss of rectal reservoir or maintenance 
of a little compliant rectal stump.22 It is likely that the diar-
rhea symptom, which was more frequent in patients sub-
mitted to radiotherapy, is an erroneous interpretation of the 
symptom, which has been often observed in outpatients. In 
this case, the patients tend to characterize fecal urgency and 
fecal incontinence as diarrhea. Dahlberg et al.23 compared pa-
tients undergoing TME that received preoperative radiothera-
py with those who did not. They observed that incontinence, 
urgency and difficulty were more important in irradiated pa-
tients. This study indicates that high doses of radiation affect 
bowel function at long-term. Thus, these specific effects of 
radiotherapy on anal continence should be discussed clearly 
and directly with the patient prior to performing multimodal 
treatment for rectal cancer. 
Studies indicate that QOL after surgery for rectal cancer 
is dynamic,24,25 being usually worse in the early postoperative 
period and improving with time. This time of improvement 
is variable in different studies and depends on the items as-
sessed. The disease itself, apart from the consequences of its 
treatment, has a major impact on QoL.26
Patients with longer postoperative follow-up did not show 
significantly higher scores in their overall health status, or 
other variables related to QOL, when compared to patients 
with shorter postoperative follow-up. This was probably due 
to the fact that all patients were in the late postoperative pe-
riod and as time goes by, they tend to increase resilience and 
coping capacity towards the situations brought on by the sur-
gery. Furthermore, enough time had passed for the body to 
adapt to the changes caused by the surgical intervention. The 
distal colon started to acquire fecal storage capacity, which 
was once a function of the rectum, while the proximal colon 
increased its absorptive capacity. In turn, the pelvic inflam-
matory process has started to decline, reducing aggression to 
the pelvic innervation.25,27 Other studies have also shown that 
the results related to quality of life function scales stabilized 
after 12 months postoperatively.25,27
The present study showed that an anastomosis more dis-
tant from the anal verge did not improve the quality of life of 
patients, which is in agreement with other authors, who also 
observed that the level of the anastomosis does not seem to 
affect functional outcomes related to quality of life.23,28 Guren 
et al.29 demonstrated that patients with an anastomosis up 
to 3 cm from the anal verge have more incontinence for gas 
and solid stools, when compared with patients with higher 
anastomoses. However, these authors found no difference 
in quality of life scores between patients with high and low 
anastomoses, as well as no linear association between the 
level of the anastomosis and fecal urgency, incontinence, or 
incomplete defecation. 
Montesani et al.30 observed that patients with anastomo-
ses distant > 6 cm from the anal verge had the same func-
tion as an intact rectum, including compliance. Functional 
alterations such as fecal incontinence (5%), urgency (5%) and 
difficulty (10%) were observed in patients with anastomoses 
between 4 and 6 cm from the anal verge, being even more 
pronounced in patients submitted to coloanal anastomosis. 
These worse results seem to be the consequence of the loss 
of rectal reservoir function and low compliance of the small 
residual rectum, hence the indication by some authors, to cre-
ate colonic reservoirs to act as a “neo-rectum”.31,32,33
The only statistically significant result found in this study, 
concerning the height of the anastomosis, was that patients 
with a distance from the anastomosis to the anal verge ≥ 5.1 
cm showed a worse effect of chemotherapy (p = 0.032) when 
compared to the other groups. The effects of chemotherapy 
assessed by the questionnaire were the presence and inten-
sity of hyposalivation, alopecia and dysgeusia, which seems 
to have no relation to the height of the anastomosis in rela-
tion to the anal verge. 
Recently, Emmertsen and Laurberg proposed the use of a 
specific questionnaire to assess the impact of low rectosig-
moidectomy on bowel function and quality of life in patients 
with rectal cancer.34 The evaluation through scores for the 
intensity of the so-called “low anterior resection syndrome” 
(“LARS score”) showed significant correlation with patient 
quality of life34 and will certainly become another important 
tool for the objective functional assessment of patients sub-
mitted to surgical procedures for rectal cancer.  
Regarding the assessment of overall health status through 
the EORTC QLQ-C30 questionnaire, a mean value of 82.06 was 
observed. This means that most patients undergoing TME 
showed good quality of life in the late postoperative period. 
One possible explanation for this satisfactory result is the 
time elapsed since surgery, which results in the body’s adap-
tation to the new reality brought on by the treatment. Anoth-
er probable reason is the performance of a standardized TME 
surgery within the recommended technical and anatomical 
principles, which provides better bowel function and lower 
rates of pelvic nerve injury with less voiding and sexual dys-
function and hence, better quality of life.  
It must also be taken into account that patients submitted 
to neoadjuvant radiotherapy had overall health status scores 
similar to those who did not undergo this type of treatment. 
This may be due to the performance of radiotherapy in a ref-
erence center, by professionals dedicated to pelvic irradiation, 
which probably resulted in fewer adverse effects that affect-
ed, to a lesser extent, patient QOL.
Patients with good overall health status had better physi-
cal, emotional and social function, as well as less fatigue, bet-
ter prospects, fewer gastrointestinal symptoms and bowel 
movement problems. These items are certainly related to 
a better or worse overall health assessment, directly influ-
encing patients’ perception of their quality of life. However, 
it was believed to be necessary to establish this correlation, 
as it corroborates which main factors should be corrected or 
improved to provide better patient QOL. However, we found 
no studies in the literature that correlated overall health sta-
tus with the other functional scales and symptoms assessed 
through questionnaires. 
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Conclusion
Most patients submitted to TME have a satisfactory quality 
of life one year after the surgery, although there were differ-
ences between the genders.
The patient’s age and the performance of preopera-
tive radiotherapy influence the risk of worsening of sexual 
function and urinary disorders and increased bowel move-
ment problems. The postoperative time and the distance 
from the anastomosis to the anal verge did not significantly 
influence the QoL of assessed patients. The main items that 
positively influenced the overall health status were physi-
cal function, social and emotional function, fatigue, future 
prospects, gastrointestinal symptoms and bowel move-
ment disorders. 
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